These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 3493622

  • 1. Tissue culture model for studying MPTP toxicity to dopamine neurons.
    Mytilineou C, Cohen G.
    Adv Neurol; 1987; 45():145-8. PubMed ID: 3493622
    [No Abstract] [Full Text] [Related]

  • 2. Studies on the mechanism of the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Heikkila RE, Nicklas WJ, Duvoisin RC.
    Adv Neurol; 1987; 45():149-52. PubMed ID: 3103384
    [No Abstract] [Full Text] [Related]

  • 3. Comparative toxicity of MPTP, MPP+ and 3,3-dimethyl-MPDP+ to dopaminergic neurons of the rat substantia nigra.
    Sayre LM, Arora PK, Iacofano LA, Harik SI.
    Eur J Pharmacol; 1986 May 13; 124(1-2):171-4. PubMed ID: 3487462
    [Abstract] [Full Text] [Related]

  • 4. On the mechanisms underlying 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity: the effect of perinigral infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, its metabolite and their analogs in the rat.
    Harik SI, Schmidley JW, Iacofano LA, Blue P, Arora PK, Sayre LM.
    J Pharmacol Exp Ther; 1987 May 13; 241(2):669-76. PubMed ID: 2437293
    [Abstract] [Full Text] [Related]

  • 5. 1-Methyl-4-phenylpyridine (MPP+) is toxic to mesencephalic dopamine neurons in culture.
    Mytilineou C, Cohen G, Heikkila RE.
    Neurosci Lett; 1985 Jun 04; 57(1):19-24. PubMed ID: 3875812
    [Abstract] [Full Text] [Related]

  • 6. Toxic effects of potential environmental neurotoxins related to 1-methyl-4-phenylpyridinium on cultured rat dopaminergic neurons.
    Michel PP, Dandapani BK, Sanchez-Ramos J, Efange S, Pressman BC, Hefti F.
    J Pharmacol Exp Ther; 1989 Feb 04; 248(2):842-50. PubMed ID: 2783974
    [Abstract] [Full Text] [Related]

  • 7. Endogenous analogs of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: indoleamine derived tetrahydro-beta-carbolines as potential causative factors in Parkinson's disease.
    Collins MA, Neafsey EJ, Cheng BY, Hurley-Gius K, Ung-Chhun NA, Pronger DA, Christensen MA, Hurley-Gius D.
    Adv Neurol; 1987 Feb 04; 45():179-82. PubMed ID: 3493625
    [No Abstract] [Full Text] [Related]

  • 8. Mitochondrial and metabolic toxicity of 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine.
    Kindt MV, Heikkila RE, Nicklas WJ.
    J Pharmacol Exp Ther; 1987 Sep 04; 242(3):858-63. PubMed ID: 3498818
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of types A and B monoamine oxidase by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Fuller RW, Hemrick-Luecke SK.
    J Pharmacol Exp Ther; 1985 Mar 04; 232(3):696-701. PubMed ID: 3871853
    [Abstract] [Full Text] [Related]

  • 10. MPP(+)-like neurotoxicity of a pyridinium metabolite derived from haloperidol: in vivo microdialysis and in vitro mitochondrial studies.
    Rollema H, Skolnik M, D'Engelbronner J, Igarashi K, Usuki E, Castagnoli N.
    J Pharmacol Exp Ther; 1994 Jan 04; 268(1):380-7. PubMed ID: 8301579
    [Abstract] [Full Text] [Related]

  • 11. Synthesis and toxicity toward nigrostriatal dopamine neurons of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) analogues.
    Fries DS, de Vries J, Hazelhoff B, Horn AS.
    J Med Chem; 1986 Mar 04; 29(3):424-7. PubMed ID: 3485197
    [Abstract] [Full Text] [Related]

  • 12. The toxic actions of MPTP and its metabolite MPP+ are not mimicked by analogues of MPTP lacking an N-methyl moiety.
    Bradbury AJ, Costall B, Domeney AM, Testa B, Jenner PG, Marsden CD, Naylor RJ.
    Neurosci Lett; 1985 Oct 24; 61(1-2):121-6. PubMed ID: 2417166
    [Abstract] [Full Text] [Related]

  • 13. Studies with the neurotoxicant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and several of its analogs.
    Heikkila RE, Youngster SK, Panek DU, Giovanni A, Sonsalla PK.
    Toxicology; 1988 May 24; 49(2-3):493-501. PubMed ID: 3259742
    [Abstract] [Full Text] [Related]

  • 14. Studies on species sensitivity to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Part 1: Systemic administration.
    Giovanni A, Sieber BA, Heikkila RE, Sonsalla PK.
    J Pharmacol Exp Ther; 1994 Sep 24; 270(3):1000-7. PubMed ID: 7932147
    [Abstract] [Full Text] [Related]

  • 15. FGF-2-mediated protection of cultured mesencephalic dopaminergic neurons against MPTP and MPP+: specificity and impact of culture conditions, non-dopaminergic neurons, and astroglial cells.
    Otto D, Unsicker K.
    J Neurosci Res; 1993 Mar 01; 34(4):382-93. PubMed ID: 8097265
    [Abstract] [Full Text] [Related]

  • 16. Brain dialysis in conscious rats reveals an instantaneous massive release of striatal dopamine in response to MPP+.
    Rollema H, Damsma G, Horn AS, De Vries JB, Westerink BH.
    Eur J Pharmacol; 1986 Jul 31; 126(3):345-6. PubMed ID: 3489628
    [No Abstract] [Full Text] [Related]

  • 17. Toxins and Parkinson's disease: MPTP parkinsonism in humans and animals.
    Kopin IJ.
    Adv Neurol; 1987 Jul 31; 45():137-44. PubMed ID: 3493621
    [No Abstract] [Full Text] [Related]

  • 18. The toxicity of MPTP to dopamine neurons in culture is reduced at high concentrations.
    Friedman L, Mytilineou C.
    Neurosci Lett; 1987 Aug 18; 79(1-2):65-72. PubMed ID: 2890125
    [Abstract] [Full Text] [Related]

  • 19. The influence of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on the levels of dopamine, serotonin and their metabolites in the caudate nucleus of the rat.
    Russ H, Henning K, Eckhardt H, Przuntek H.
    Arzneimittelforschung; 1985 Aug 18; 35(2):481-2. PubMed ID: 2581589
    [Abstract] [Full Text] [Related]

  • 20. A high dose of MPTP overcomes the protective effect of selegiline against dopaminergic neurotoxicity.
    Fuller RW, Hemrick-Luecke SK.
    J Pharm Pharmacol; 1989 Jul 18; 41(7):492-3. PubMed ID: 2570859
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.